Literature DB >> 34321678

Incidence of Hepatitis C Virus and Other Bloodborne Virus Infections Among Nonurban Residents of Fairfield and New Haven Counties, Connecticut Who Inject Drugs.

Samantha H Batman1, Lauretta E Grau2, Robert Heimer2.   

Abstract

Opioid overdose and substance abuse treatment entry data suggest that injection drug use is increasing in nonurban locations. We sought to explore the prevalence and incidence of viral infections among people who inject drugs (PWID) residing in Fairfield and New Haven counties but outside of the six largest cities. A longitudinal cohort of PWID was assembled and incidence of HIV-1, hepatitis B virus, and hepatitis C virus infections was determined by annual antibody screening. Data on participants' socioeconomic situation and risk behaviors were collected. We identified 11 new hepatitis C virus infections and calculated incidence at 9.03 cases per 100 person-years. Only one new HIV infection and one new hepatitis B virus infection were detected. Factors associated with seroconversion were assessed. Given the high incidence of HCV and lack of HBV vaccination coverage, prevention and treatment resources need to be targeted to this population.

Entities:  

Keywords:  HIV; Hepatitis C virus; harm reduction; hepatitis B; injection drug users; seroincidence; spatial analysis; suburbs

Year:  2018        PMID: 34321678      PMCID: PMC8315100     

Source DB:  PubMed          Journal:  Conn Med        ISSN: 0010-6178


  11 in total

1.  Prevalence and experience of chronic pain in suburban drug injectors.

Authors:  Robert Heimer; Weihai Zhan; Lauretta E Grau
Journal:  Drug Alcohol Depend       Date:  2015-03-19       Impact factor: 4.492

2.  Payers consider waiting out budget-busting hepatitis C drug.

Authors:  John Carroll
Journal:  Manag Care       Date:  2014-05

3.  An inventory for measuring clinical anxiety: psychometric properties.

Authors:  A T Beck; N Epstein; G Brown; R A Steer
Journal:  J Consult Clin Psychol       Date:  1988-12

4.  Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention.

Authors:  Kimberly Page; Meghan D Morris; Judith A Hahn; Lisa Maher; Maria Prins
Journal:  Clin Infect Dis       Date:  2013-08       Impact factor: 9.079

Review 5.  Evolving epidemiology of hepatitis C virus in the United States.

Authors:  R Monina Klevens; Dale J Hu; Ruth Jiles; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-07       Impact factor: 9.079

6.  Syringe exchange programs --- United States, 2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-11-19       Impact factor: 17.586

7.  Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain.

Authors:  San Keller; Carla M Bann; Sheri L Dodd; Jeff Schein; Tito R Mendoza; Charles S Cleeland
Journal:  Clin J Pain       Date:  2004 Sep-Oct       Impact factor: 3.442

Review 8.  Best strategies for global HCV eradication.

Authors:  Liesl M Hagan; Raymond F Schinazi
Journal:  Liver Int       Date:  2013-02       Impact factor: 5.828

9.  Seroprevalence of HIV, hepatitis B virus, and HCV among injection drug users in Connecticut: understanding infection and coinfection risks in a nonurban population.

Authors:  Hana Akselrod; Lauretta E Grau; Russell Barbour; Robert Heimer
Journal:  Am J Public Health       Date:  2013-10-17       Impact factor: 9.308

10.  Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015.

Authors:  Caitlin Conrad; Heather M Bradley; Dita Broz; Swamy Buddha; Erika L Chapman; Romeo R Galang; Daniel Hillman; John Hon; Karen W Hoover; Monita R Patel; Andrea Perez; Philip J Peters; Pam Pontones; Jeremy C Roseberry; Michelle Sandoval; Jessica Shields; Jennifer Walthall; Dorothy Waterhouse; Paul J Weidle; Hsiu Wu; Joan M Duwve
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-01       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.